The GvHD Hub spoke with Corey Cutler, Dana-Farber Cancer Institute, Boston, US. We asked, What approaches could improve recruitment and retention in cGvHD clinical trials?
During this interview, Cutler discusses strategies to promote recruitment and retention of patients in chronic graft-versus-host disease (cGvHD) clinical trials. He highlights the importance of broad eligibility criteria, as well as opportunities for patients to participate in both therapeutic and non-therapeutic cGvHD research. He also emphasizes the need to consider the patient perspective when designing trials, including the time, travel, and assessment burden associated with participation.
Intended for healthcare professionals. This educational resource is independently supported by Sanofi. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.
","author_name":"Scientific Education Support"}